Glutamine (Pharmacological doses)

DRUG2 trials

Sponsors

Boston Medical Center, Ain Shams University

Conditions

CancerDiabetesNeuropathy

Phase 1

Novel Type 2 Diabetes Mellitus Preventive Therapies

CompletedNCT02351323

Boston Medical CenterDiabetes

Start: 2010-05-31End: 2014-08-31Updated: 2015-01-30

Phase 3

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Not yet recruitingNCT07287592

Ain Shams UniversityCancer, Neuropathy

Start: 2025-12-30End: 2027-04-30Target: 70Updated: 2025-12-17